Evaluation the Role of Melatonin and Cortisol in Thalassemia Patients with Sickle Cell Anemia
DOI:
https://doi.org/10.37375/qn85fn14Keywords:
Sickle cell anemia, Thalassemia, Melatonin, CortisolAbstract
The study included the estimation of some biochemical variables in thalassemia patients with sickle cell anemia of both sexes, comparing them with a group of healthy control. The study included (43) cases collected from Al-Hadba Hospital in Mosul city and was divided into two groups: the first group consisted of 20 patients, and the second group included 23 healthy cases. Levels of melatonin and cortisol were analyzed, in addition to other blood indicators such as hemoglobin (Hb), white blood cell count (WBC), and platelets (PLT). The results showed that thalassemia patients with sickle cell anemia suffered from a significant decrease in hemoglobin levels compared to healthy individuals, along with varying increases in white blood cell and platelet counts. Moreover, melatonin concentration decreased, and cortisol increased significantly compared to the control group, with clear differences in some biomarkers between the two studied age categories. Higher levels of both melatonin and cortisol were recorded in females compared to males.
References
Ahmed, M. H., Ali, A. S., & Shakir, D. (2020). Role of melatonin in modulating oxidative stress in sickle cell disease: A potential therapeutic target. Blood Cells, Molecules, and Diseases, 83, 102433. https://doi.org/10.1016/j.bcmd.2020.102433
Ataga, K. I., Brittain, J. E., Desai, P., et al. (2012). Association of coagulation activation with clinical complications in sickle cell disease. PLOS ONE, 7(1), e29786.
Ataga, K. I., Key, N. S., & Hebbel, R. P. (2007). Hemostatic abnormalities in sickle cell disease. Blood, 110(12), 4261–4266. https://doi.org/10.1182/blood-2007-07-097964
Aygun, B., Mortier, N., Smeltzer, M., Shulkin, B., & Hankins, J. S. (2014). Hydroxyurea treatment in children with sickle cell anemia. Pediatric Blood & Cancer, 62(2), 195–199.
Bain, B. J., Bates, I., Laffan, M. A., & Lewis, S. M. (2017). Dacie and Lewis practical haematology (12th ed.). Elsevier.
Brousse, V., Buffet, P., & Rees, D. (2021). The spleen and sickle cell disease: The sick(led) spleen. British Journal of Haematology, 192(5), 787–796. https://doi.org/10.1111/bjh.17299
Cappellini, M. D., Musallam, K. M., & Taher, A. T. (2020). Beta-thalassemia: A model for precision medicine. Hematology/Oncology Clinics of North America, 34(2), 305–321. https://doi.org/10.1016/j.hoc.2019.11.008
Claustrat, B., Brun, J., & Chazot, G. (2005). The basic physiology and pathophysiology of melatonin. Sleep Medicine Reviews, 9(1), 11–24. https://doi.org/10.1016/j.smrv.2004.08.001
Dacie, J. V., & Lewis, S. M. (1995). Practical haematology (8th ed.). Churchill Livingstone.
Darbari, D. S., Onyekwere, O., Nouraie, M., et al. (2013). Markers of severe vaso-occlusive painful episode frequency in children and adolescents with sickle cell anemia. The Journal of Pediatrics, 162(1), 24–29. https://doi.org/10.1016/j.jpeds.2012.06.040
El-Far, M., Darwish, N. H. E., & Mousa, S. A. (2023). Dysregulation of cortisol and its implications in inflammatory diseases. Frontiers in Immunology, 14, 1173261. https://doi.org/10.3389/fimmu.2023.1173261
Hardeland, R. (2021). Melatonin and inflammation—Story of a double-edged blade. Journal of Pineal Research, 70(1), e12785. https://doi.org/10.1111/jpi.12785
Hassan, A. M., et al. (2022). Cortisol as a stress biomarker in sickle cell-thalassemia patients: A case-control study. Egyptian Journal of Hematology, 47(1), 15–22.
Ibrahim, M. T., et al. (2022). Elevated white blood cell count as a marker of inflammation in sickle cell-thalassemia patients. Hematology Reports, 14(2), 45–53.
Kumar, S., et al. (2021). Platelet count variations in patients with sickle cell-thalassemia syndrome. Journal of Clinical Pathology, 74(3), 198–204.
Lupien, S. J., et al. (2009). Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nature Reviews Neuroscience, 10(6), 434–445.
Mohamed, E. E., El-Awady, R. A., & Omar, H. A. (2023). Dysregulated cortisol and oxidative imbalance in sickle cell disease: Potential targets for therapy. Free Radical Biology and Medicine, 200, 135–146. https://doi.org/10.1016/j.freeradbiomed.2023.01.012
Musallam, K. M., Rivella, S., Vichinsky, E., & Rachmilewitz, E. A. (2012). Non-transfusion-dependent thalassemias. Haematologica, 98(6), 833–844. https://doi.org/10.3324/haematol.2012.066845
Nelson, D. L., & Cox, M. M. (2017). Lehninger principles of biochemistry (7th ed.). W.H. Freeman.
Oliveira, A. F., et al. (2020). Hemoglobin levels in patients with sickle cell-thalassemia: A cross-sectional study. Annals of Hematology, 99(5), 1021–1028. https://doi.org/10.1007/s00277-020-04007-5
Sood, R. (1996). Medical laboratory technology: Methods and interpretations (5th ed.). Jaypee Brothers.
Taher, A. T., Musallam, K. M., & Cappellini, M. D. (2018). Thalassemia intermedia: An update. Mediterranean Journal of Hematology and Infectious Diseases, 10(1), e2018031. https://doi.org/10.4084/MJHID.2018.031
Voskaridou, E., Christoulas, D., Terpos, E., & Kattamis, A. (2020). Management of sickle cell disease and thalassemia in adults. Blood Reviews, 44, 100676.
Ware, R. E., de Montalembert, M., Tshilolo, L., & Abboud, M. R. (2017). Sickle cell disease. The Lancet, 390(10091), 311–323. https://doi.org/10.1016/S0140-6736(17)30193-9
Yilmaz, O., et al. (2023). Melatonin levels and oxidative stress in sickle cell-thalassemia patients. Turkish Journal of Hematology, 40(1), 30–38.
Zhao, Y., Wang, Q., & Liu, L. (2022). Aging and melatonin secretion: A cross-sectional study. Journal of Pineal Research, 72(3), e12845.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Scientific Journal for Faculty of Science-Sirte University
This work is licensed under a Creative Commons Attribution 4.0 International License.
